StockData
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc. (WHWK) stock

WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.08+0.07 (+2.33%)

Close on Nov 17, 2026Market cap $175.59MP/E –Yield –

Whitehawk Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Whitehawk Therapeutics's profit margin for the twelve months ending Dec 31, 2025 was -288.3%. For fiscal 2025 it was -288.3%, against -245.1% the year before. The highest annual figure on record is -24.8% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-288.3%−43.1
FY2024Dec 31, 2024-245.1%+24.9
FY2023Dec 31, 2023-270.0%+127.7
FY2022Dec 31, 2022-397.7%+388.7
FY2021Dec 31, 2021-786.4%−761.5
FY2020Dec 31, 2020-24.8%+26.7
FY2018Dec 31, 2018-51.6%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2025Mar 31, 20251021.9%+1363.6
Q4 FY2024Dec 31, 2024-252.4%+4.8
Q3 FY2024Sep 30, 2024-174.0%+99.6
Q2 FY2024Jun 30, 2024-236.0%+53.8
Q1 FY2024Mar 31, 2024-341.7%−82.2
Q4 FY2023Dec 31, 2023-257.2%+9.0
Q3 FY2023Sep 30, 2023-273.6%+67.4
Q2 FY2023Jun 30, 2023-289.8%+241.8
Q1 FY2023Mar 31, 2023-259.5%+341.2
Q4 FY2022Dec 31, 2022-266.2%−151.0
Q3 FY2022Sep 30, 2022-341.0%+4222.4
Q2 FY2022Jun 30, 2022-531.5%−590.6
Q1 FY2022Mar 31, 2022-600.7%+651.3
Q4 FY2021Dec 31, 2021-115.2%−80.0
Q1 FY2021Mar 31, 2021-4563.3%+392758.9
Q4 FY2020Dec 31, 202059.1%−2.2
Q3 FY2020Sep 30, 2020-1251.9%−802.7
Q2 FY2020Jun 30, 2020-35.2%–
Q4 FY2018Dec 31, 2018-397322.2%–
Q3 FY2018Sep 30, 201861.3%–
Q2 FY2018Jun 30, 2018-449.2%–

More Whitehawk Therapeutics figures

See a number that looks wrong?